![LONG-TERM OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION.... EHA Library. Gavriilaki E. May 16 2019; 268223 LONG-TERM OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION.... EHA Library. Gavriilaki E. May 16 2019; 268223](https://library.ehaweb.org/image/abstract/eha_2019/EHA-2192/ImagePictures_6998052.jpg)
LONG-TERM OUTCOMES OF ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION.... EHA Library. Gavriilaki E. May 16 2019; 268223
![Transplant‐associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation - Gavriilaki - 2018 - Clinical Transplantation - Wiley Online Library Transplant‐associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation - Gavriilaki - 2018 - Clinical Transplantation - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/af759ccb-6d89-49d8-91ba-7d9a6427ec5e/ctr.2018.32.issue-9.cover.jpg)
Transplant‐associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation - Gavriilaki - 2018 - Clinical Transplantation - Wiley Online Library
![Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes - ScienceDirect Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497118724087-gr1.jpg)
Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes - ScienceDirect
![Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells - Experimental Hematology Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells - Experimental Hematology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/07419fd1-6c83-41e9-b8cb-293a0c3ae3dd/gr1.jpg)
Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells - Experimental Hematology
![Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single‐center study - Sakellari - 2018 - Journal of Clinical Apheresis - Wiley Online Library Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single‐center study - Sakellari - 2018 - Journal of Clinical Apheresis - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/e7239571-f573-482d-9c96-4aae04c7ae90/jca.v33.6.cover.jpg)
Favorable impact of extracorporeal photopheresis in acute and chronic graft versus host disease: Prospective single‐center study - Sakellari - 2018 - Journal of Clinical Apheresis - Wiley Online Library
![Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine](https://www.frontiersin.org/files/Articles/608165/fmed-07-608165-HTML/image_m/fmed-07-608165-g001.jpg)
Frontiers | Risk Factors and Outcomes of Klebsiella pneumoniae Infection Before and After Allogeneic Hematopoietic Cell Transplantation | Medicine
![BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma | Bone Marrow Transplantation BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-018-0395-y/MediaObjects/41409_2018_395_Fig1_HTML.png)
BEAC (carmustine, etoposide, cytarabine, and cyclophosphamide) in autologous hematopoietic cell transplantation: a safe and effective alternative conditioning regimen for Hodgkin and non-Hodgkin lymphoma | Bone Marrow Transplantation
![Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic. - ppt download Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic. - ppt download](https://slideplayer.com/90/14522484/big_thumb.jpg)
Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic. - ppt download
Yiannis Batsis, SHRM-SCP - Learning & Development Partner, EMEA - Wyndham Hotels & Resorts | LinkedIn
![Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic. - ppt download Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic. - ppt download](https://slideplayer.com/17750946/105/images/slide_1.jpg)
Survival Advantage and Comparable Toxicity in Reduced-Toxicity Treosulfan-Based versus Reduced-Intensity Busulfan-Based Conditioning Regimen in Myelodysplastic. - ppt download
![BATSIS CHRISTOS - BATSIS IOANNIS OE Meat Market Equipment | Monolofo Thessaloniki | +302310724950 | xo.gr BATSIS CHRISTOS - BATSIS IOANNIS OE Meat Market Equipment | Monolofo Thessaloniki | +302310724950 | xo.gr](https://st0.xo.gr/files/1/Backoffice/customer_logos/avatar-tarasidis-a-christos-28bcc5500147466ca7b00b4713b82256.jpg)
BATSIS CHRISTOS - BATSIS IOANNIS OE Meat Market Equipment | Monolofo Thessaloniki | +302310724950 | xo.gr
![The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706) | Bone Marrow Transplantation The 46th Annual Meeting of the European Society for Blood and Marrow Transplantation: Physicians Poster Session (P001-P706) | Bone Marrow Transplantation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41409-020-01120-w/MediaObjects/41409_2020_1120_Figa_HTML.png)